Charles Giardina
- Molecular Biology top 2%
- Cancer Research top 2%
- Oncology top 5%
- Immunology top 5%
- Genetics top 5%
- Co-authors
- Daniel W. RosenbergJohn T. LisEmily J. NoonanAndrea K. HubbardRobert F. PlaceLei YinMehmet Sait InanTakuya Tanaka
- Topics
- NF-κB Signaling Pathways (15 papers)Histone Deacetylase Inhibitors Research (9 papers)Cancer-related Molecular Pathways (9 papers)
- Partner nations
- United StatesIranJapan
In The Last Decade
Charles Giardina
90 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 141
- Molecular Biology 2.9k
- Cancer Research 882
- Oncology 715
- Immunology 527
- Genetics 434
Countries citing papers authored by Charles Giardina
This map shows the geographic impact of Charles Giardina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Giardina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Giardina more than expected).
Fields of papers citing papers by Charles Giardina
This network shows the impact of papers produced by Charles Giardina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Giardina. The network helps show where Charles Giardina may publish in the future.
Co-authorship network of co-authors of Charles Giardina
This figure shows the co-authorship network connecting the top 25 collaborators of Charles Giardina. A scholar is included among the top collaborators of Charles Giardina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Giardina. Charles Giardina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 99 | |
| 5 | 8 | |
| 6 | 15 | |
| 7 | 20 | |
| 8 | 19 | |
| 9 | 14 | |
| 10 | 5 | |
| 11 | 6 | |
| 12 | 72 | |
| 13 | 33 | |
| 14 | 89 | |
| 15 | 16 | |
| 16 | 23 | |
| 17 | 113 | |
| 18 | 83 | |
| 19 | 95 | |
| 20 | 39 |
About Charles Giardina
Charles Giardina is a scholar working on Aging, Cancer Research and Oncology, having authored 92 papers that have together received 4.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (15 papers), Histone Deacetylase Inhibitors Research (9 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Cancer Research (882 citations), Molecular Biology (2.9k citations) and Aging (67 citations). Charles Giardina has collaborated with scholars based in United States, Iran and Japan. Frequent co-authors include Daniel W. Rosenberg, John T. Lis, Emily J. Noonan, Andrea K. Hubbard, Robert F. Place, Lei Yin, Mehmet Sait Inan, Takuya Tanaka, Lawrence E. Hightower and Gary Laevsky. Their work appears in journals such as Science, Journal of Biological Chemistry and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.